theophylline has been researched along with Chronic Hepatitis in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Therefore, the aim of this study was to evaluate the influence of chronic hepatitis (CH), liver cirrhosis (LC), and other covariates on theophylline clearance by population pharmacokinetic (PPK) analysis." | 5.56 | Differences in Theophylline Clearance Between Patients With Chronic Hepatitis and Those With Liver Cirrhosis. ( Araki, H; Hirota, T; Ieiri, I; Kashihara, Y; Kurata, Y; Muraki, S, 2020) |
| "1 day after a single intramuscular injection of recombinant human interferon alpha A in 5 patients with stable chronic active hepatitis B and 4 healthy controls theophylline clearance was significantly reduced and theophylline elimination half-life was significantly increased." | 3.67 | Inhibition of theophylline metabolism by interferon. ( Baird-Lambert, JA; Farrell, GC; Williams, SJ, 1987) |
| "In 272 patients with virus hepatitis A and B the content of theophylline-sensitive lymphocytes (T-suppressors) and theophylline-resistant lymphocytes (T-helpers) in the peripheral blood was determined." | 3.67 | [Characteristics of immune response regulation in viral hepatitis A and B]. ( Bliuger, AF; Charnaia, RG; Novitskiĭ, IN; Osna, NA; Veksler, KhM, 1985) |
| "Subjects with liver cirrhosis and chronic hepatitis, as well as healthy volunteers, were given the oral dose of 300 mg caffeine." | 2.71 | Serum metabolite/caffeine ratios as a test for liver function. ( Flieger, J; Jodynis-Liebert, J; Juszczyk, J; Matuszewska, A, 2004) |
| " Therefore, the aim of this study was to evaluate the influence of chronic hepatitis (CH), liver cirrhosis (LC), and other covariates on theophylline clearance by population pharmacokinetic (PPK) analysis." | 1.56 | Differences in Theophylline Clearance Between Patients With Chronic Hepatitis and Those With Liver Cirrhosis. ( Araki, H; Hirota, T; Ieiri, I; Kashihara, Y; Kurata, Y; Muraki, S, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurata, Y | 1 |
| Muraki, S | 1 |
| Kashihara, Y | 1 |
| Hirota, T | 1 |
| Araki, H | 1 |
| Ieiri, I | 1 |
| Jodynis-Liebert, J | 1 |
| Flieger, J | 1 |
| Matuszewska, A | 1 |
| Juszczyk, J | 1 |
| Amodio, P | 1 |
| Lauro, S | 1 |
| Rondana, M | 1 |
| Crema, G | 1 |
| Merkel, C | 1 |
| Gatta, A | 1 |
| Ruol, A | 1 |
| Williams, SJ | 1 |
| Baird-Lambert, JA | 1 |
| Farrell, GC | 1 |
| Bliuger, AF | 1 |
| Veksler, KhM | 1 |
| Osna, NA | 1 |
| Charnaia, RG | 1 |
| Novitskiĭ, IN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Development of a Breath Test for Monitoring Liver Metabolic Function in Patients With Chronic Liver Disease and Cirrhosis[NCT00244569] | Phase 3 | 120 participants (Anticipated) | Interventional | 2005-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for theophylline and Chronic Hepatitis
| Article | Year |
|---|---|
Serum metabolite/caffeine ratios as a test for liver function.
Topics: Adult; Caffeine; Female; Hepatitis, Chronic; Humans; Liver; Liver Cirrhosis; Liver Function Tests; M | 2004 |
4 other studies available for theophylline and Chronic Hepatitis
| Article | Year |
|---|---|
Differences in Theophylline Clearance Between Patients With Chronic Hepatitis and Those With Liver Cirrhosis.
Topics: Adult; Hepatitis, Chronic; Humans; Kinetics; Liver Cirrhosis; Retrospective Studies; Theophylline | 2020 |
Theophylline pharmacokinetics and liver function indexes in chronic liver disease.
Topics: Adult; Aged; Female; Hepatitis, Chronic; Humans; Liver; Liver Cirrhosis; Male; Metabolic Clearance R | 1991 |
Inhibition of theophylline metabolism by interferon.
Topics: Adult; Drug Evaluation; Drug Interactions; Female; Half-Life; Hepatitis B; Hepatitis, Chronic; Human | 1987 |
[Characteristics of immune response regulation in viral hepatitis A and B].
Topics: Carrier State; Hepatitis A; Hepatitis B; Hepatitis, Chronic; Humans; Leukocyte Count; T-Lymphocytes, | 1985 |